Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Frontiers in Systems Neuroscience|August 23, 2013
Decision-making in information seeking on texts: an eye-fixation-related potentials investigationAline Frey, Gelu Ionescu, Benoit Lemaire, et al.Advances in Therapy|August 23, 2019
Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient SurveyOlivier Morand, Jack Johnson, Jerry Walter, et al.Molecular Genetics and Metabolism Reports|July 5, 2022
Understanding and modifying Fabry disease: Rationale and design of a pivotal Phase 3 study and results from a patient-reported outcome validation studyChristoph Wanner, Virginia Kimonis, Juan Politei, et al.American Heart Journal|October 3, 2002
Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4)Christopher M O'Connor, Wendy A Gattis, Kirkwood F Adams, et al.Stroke|August 9, 2008
Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trialR Loch Macdonald, Neal F Kassell, Stephan Mayer, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II StudyChristopher P Denton, Éric Hachulla, Gabriela Riemekasten, et al.Journal of Cardiac Failure|September 30, 2009
Early worsening heart failure in patients admitted for acute heart failure: time course, hemodynamic predictors, and outcomeGuillermo Torre-Amione, Olga Milo-Cotter, Edo Kaluski, et al.Journal of the American College of Cardiology|January 22, 2003
RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled studyEdo Kaluski, Isaac Kobrin, Reuven Zimlichman, et al.Journal of the American College of Cardiology|May 14, 2003
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)Christopher M O'Connor, Wendy A Gattis, Kirkwood F Adams, et al.European Journal of Heart Failure|August 10, 2005
Echocardiographic ejection fraction in patients with acute heart failure: correlations with hemodynamic, clinical, and neurohormonal measures and short-term outcomeNir Uriel, Guillermo Torre-Amione, Olga Milo, et al.Pageof 4